This announcement is a separate document:
奥锐特：奥锐特药业股份有限公司监事会关于公司2022年限制性股票激励计划授予相关事项的核查意见
Orete: Audit opinion of the Supervisory Board of Orete Pharmaceutical Co., Ltd. on matters relating to the grant of the company's 2022 restricted stock incentive plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.